$TRTX Balance Sheet | Understand Stock

$TRTX

$6.30 +$0.05 (0.8%) Close

$TRTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2026 As of Sep 30, 2026	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
Assets
Cash and cash equivalents
Restricted cash
Accounts receivable
Collateralized loan obligation proceeds held at trustee
Accounts receivable from servicer/trustee
Accrued interest and fees receivable
Loans held for investment
Allowance for credit losses
Loans held for investment, net
Real estate owned, net
Other assets
Total assets
Liabilities and stockholders’ equity
Liabilities
Accrued interest payable
Accrued expenses and other liabilities
Collateralized loan obligations, net, Asset-specific financings, net, Mortgage loan payable, net
Collateralized loan obligations
Asset-specific financing arrangements
Mortgage loans payable
Total collateralized loan obligations, net, Asset-specific financings, net, Mortgage loan payable, net

Secured financing agreements, net
Asset-specific financings, net
Collateralized loan obligations, net
Collateralized loan obligations
Asset-specific financing arrangements
Mortgage loans payable
Total collateralized loan obligations, net
Payable to affiliates
Affiliated Entity
Total payable to affiliates

Deferred revenue
Dividends payable
Total liabilities

Series B Preferred Stock ($0.001 par value per share; 13,000,000 and 13,000,000 shares authorized, respectively; 0 and 0 shares issued and outstanding, respectively)
Stockholders' equity
Preferred stock
Series A Preferred Stock
Series C Preferred Stock
Common stock ($0.001 par value per share; 302,500,000 and 302,500,000 shares authorized, respectively; 75,826,954 and 78,318,722 shares issued and outstanding, respectively)
Common Stock, Undefined Class
Total common stock ($0.001 par value per share; 302,500,000 and 302,500,000 shares authorized, respectively; 75,826,954 and 78,318,722 shares issued and outstanding, respectively)

Additional paid-in-capital
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Comments